Hester Biosciences Limited (BOM: 524669)
India
· Delayed Price · Currency is INR 2,468.60
-26.40 (-1.06%)
At close: Nov 14, 2024
Hester Biosciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | 234.69 | 188.89 | 266.27 | 393.2 | 344.3 | 291.71 | Upgrade
|
| Depreciation & Amortization | 157.16 | 170.64 | 205.73 | 165.27 | 132.64 | 131.78 | Upgrade
|
| Other Amortization | 1.1 | 1.1 | 1.22 | 0.54 | 0.5 | 0.52 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.15 | -0.28 | -0.16 | -0.69 | 23.22 | -4.57 | Upgrade
|
| Loss (Gain) on Equity Investments | -35.04 | -46.09 | -44.09 | -4.23 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 3.43 | 7.12 | 5.28 | 24.57 | 9.77 | 0.62 | Upgrade
|
| Other Operating Activities | 163.73 | 123.71 | 10.09 | -103.74 | 54.63 | 85.12 | Upgrade
|
| Change in Accounts Receivable | 55.75 | 3.95 | -249.65 | -87.79 | 82.47 | -256.33 | Upgrade
|
| Change in Inventory | 131.83 | 92.29 | -94.28 | -131.6 | 17.46 | -131.82 | Upgrade
|
| Change in Accounts Payable | -52.6 | -35.41 | 119.64 | -100.67 | 80.63 | 98.63 | Upgrade
|
| Change in Other Net Operating Assets | 6.14 | -24.58 | 15.91 | -67.74 | -165.09 | 152.06 | Upgrade
|
| Operating Cash Flow | 666.04 | 481.34 | 235.96 | 87.12 | 580.53 | 367.72 | Upgrade
|
| Operating Cash Flow Growth | 192.02% | 103.99% | 170.84% | -84.99% | 57.87% | -21.27% | Upgrade
|
| Capital Expenditures | -234.73 | -243.97 | -777.62 | -957.1 | -407.42 | -734.98 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.39 | 0.55 | 0.25 | 1.79 | 0.42 | 9.81 | Upgrade
|
| Investment in Securities | -3.76 | -2.06 | 2.28 | -213.21 | 10.6 | -23.3 | Upgrade
|
| Other Investing Activities | 19.14 | 18.94 | 5.1 | 2.64 | 12.68 | 3.74 | Upgrade
|
| Investing Cash Flow | -218.96 | -226.54 | -769.99 | -1,166 | -383.72 | -744.73 | Upgrade
|
| Short-Term Debt Issued | - | - | 240.13 | 315.66 | - | 100.44 | Upgrade
|
| Long-Term Debt Issued | - | 204.74 | 320.44 | 1,033 | 182.11 | 181.25 | Upgrade
|
| Total Debt Issued | 136.78 | 204.74 | 560.57 | 1,349 | 182.11 | 281.69 | Upgrade
|
| Short-Term Debt Repaid | - | -275.07 | - | - | -292.64 | - | Upgrade
|
| Long-Term Debt Repaid | - | -232.66 | -172 | -181.18 | -118.44 | - | Upgrade
|
| Total Debt Repaid | -422.64 | -507.73 | -172 | -181.18 | -411.08 | - | Upgrade
|
| Net Debt Issued (Repaid) | -285.86 | -302.99 | 388.57 | 1,168 | -228.97 | 281.69 | Upgrade
|
| Common Dividends Paid | -51.04 | -68.05 | -85.07 | -85.07 | -56.15 | -59.55 | Upgrade
|
| Other Financing Activities | -115.23 | 110.59 | 114.08 | 32.48 | 102.93 | -34.71 | Upgrade
|
| Financing Cash Flow | -452.13 | -260.45 | 417.58 | 1,115 | -182.19 | 187.43 | Upgrade
|
| Foreign Exchange Rate Adjustments | 10.3 | 1.57 | 0.51 | -1.79 | -37.24 | 18.42 | Upgrade
|
| Net Cash Flow | 5.25 | -4.08 | -115.94 | 34.81 | -22.62 | -171.16 | Upgrade
|
| Free Cash Flow | 431.31 | 237.37 | -541.66 | -869.98 | 173.11 | -367.26 | Upgrade
|
| Free Cash Flow Margin | 13.63% | 7.63% | -19.47% | -35.27% | 7.95% | -19.56% | Upgrade
|
| Free Cash Flow Per Share | 50.96 | 27.90 | -63.67 | -102.27 | 20.35 | -43.17 | Upgrade
|
| Cash Interest Paid | 135.23 | 149.41 | 125.92 | 25.38 | 40.25 | 76.66 | Upgrade
|
| Cash Income Tax Paid | 122.94 | 116.66 | 81.07 | 171.09 | 139.36 | 121.6 | Upgrade
|
| Levered Free Cash Flow | 252.18 | 109.92 | -507.55 | -764.94 | 13.92 | -476.45 | Upgrade
|
| Unlevered Free Cash Flow | 310.74 | 166.92 | -475.37 | -748.84 | 51.8 | -436.52 | Upgrade
|
| Change in Net Working Capital | -66.77 | 30.41 | 167.37 | 301.57 | 43.43 | 126.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.